𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of Fas ligand as an effector molecule in corneal graft rejection

✍ Scribed by Patrick M. Stuart; Xiatang Yin; Stacey Plambeck; Fan Pan; Thomas A. Ferguson

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
196 KB
Volume
35
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The dual role of Fas-ligand as an injury
The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation
✍ Michal Pearl-Yafe; Esma S. Yolcu; Isaac Yaniv; Jerry Stein; Haval Shirwan; Nadir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

The exact process that leads to the eruption of autoimmune reactions against beta cells and the evolution of diabetes is not fully understood. Macrophages and T cells may launch an initial immune reaction against the pancreatic islets of Langerhans, provoking inflammation and destructive insulitis.

Roles of CXC chemokines and macrophages
Roles of CXC chemokines and macrophages in the recruitment of inflammatory cells and tumor rejection induced by Fas/Apo-1 (CD95) ligand-expressing tumor
✍ Motomu Shimizu; Takayuki Yoshimoto; Mayumi Sato; Junji Morimoto; Akio Matsuzawa; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 936 KB

## Abstract The role of CD95 ligand (FasL/Apo‐1L)‐expressing tumors in immunosuppression or immunopotentiation is controversial. CD95L‐transfected tumors induce immunopotentiation after vigorous neutrophil infiltration. Thus, the induction of neutrophil infiltration by CD95L seems to play an import